Ultrastructure of nonenzymatically glycated mesangial matrix in diabetic nephropathy

Hirofumi Makino, Kenichi Shikata, K. Hironaka, M. Kushiro, Y. Yamasaki, H. Sugimoto, Z. Ota, N. Araki, S. Horiuchi

Research output: Contribution to journalArticle

139 Citations (Scopus)

Abstract

Advanced protein glycation has been proposed as a major factor in the development of diabetic nephropathy. Advanced glycation end products (AGEs) have altered the structure of extracellular matrix component and impaired self association in vitro. To elucidate the role of AGEs in the progression of diabetic nephropathy, the present study was undertaken to localize glomerular AGEs immunohistochemically. Ultrastructural changes of the mesangial matrix were analyzed with high resolution scanning electron microscopy. No glomerular AGEs staining was noted in normal control kidney specimens, or in tissue from glomerulonephritis patients without diabetes mellitus. The mesangium showed a positive AGEs staining in advanced stages of diabetic nephropathy, and the most characteristic finding was the strong AGEs staining in nodular lesions. By high resolution scanning electron microscopy, control and diabetic mesangial matrices revealed a meshwork structure composed of fine fibrils (10 nm in width) and numerous pores (12 to 13 nm in diameter). In the nodular lesions, however, loosening of the meshwork was significant, and the diameter of the pores was enlarged (approximately 24 nm). This study provides the first immunohistochemical evidence that AGEs are localized in diabetic glomeruli, most notably to nodular lesions. Advanced glycation might play a role in the progression of diabetic nephropathy through impairment of the assembly of matrix proteins in vivo.

Original languageEnglish
Pages (from-to)517-526
Number of pages10
JournalKidney International
Volume48
Issue number2
Publication statusPublished - 1995

Fingerprint

Diabetic Nephropathies
Staining and Labeling
Electron Scanning Microscopy
Advanced Glycosylation End Products
Glomerulonephritis
Extracellular Matrix
Diabetes Mellitus
Proteins
Kidney

ASJC Scopus subject areas

  • Nephrology

Cite this

Makino, H., Shikata, K., Hironaka, K., Kushiro, M., Yamasaki, Y., Sugimoto, H., ... Horiuchi, S. (1995). Ultrastructure of nonenzymatically glycated mesangial matrix in diabetic nephropathy. Kidney International, 48(2), 517-526.

Ultrastructure of nonenzymatically glycated mesangial matrix in diabetic nephropathy. / Makino, Hirofumi; Shikata, Kenichi; Hironaka, K.; Kushiro, M.; Yamasaki, Y.; Sugimoto, H.; Ota, Z.; Araki, N.; Horiuchi, S.

In: Kidney International, Vol. 48, No. 2, 1995, p. 517-526.

Research output: Contribution to journalArticle

Makino, H, Shikata, K, Hironaka, K, Kushiro, M, Yamasaki, Y, Sugimoto, H, Ota, Z, Araki, N & Horiuchi, S 1995, 'Ultrastructure of nonenzymatically glycated mesangial matrix in diabetic nephropathy', Kidney International, vol. 48, no. 2, pp. 517-526.
Makino, Hirofumi ; Shikata, Kenichi ; Hironaka, K. ; Kushiro, M. ; Yamasaki, Y. ; Sugimoto, H. ; Ota, Z. ; Araki, N. ; Horiuchi, S. / Ultrastructure of nonenzymatically glycated mesangial matrix in diabetic nephropathy. In: Kidney International. 1995 ; Vol. 48, No. 2. pp. 517-526.
@article{07132d512ba04884bac90d32aa3d03d6,
title = "Ultrastructure of nonenzymatically glycated mesangial matrix in diabetic nephropathy",
abstract = "Advanced protein glycation has been proposed as a major factor in the development of diabetic nephropathy. Advanced glycation end products (AGEs) have altered the structure of extracellular matrix component and impaired self association in vitro. To elucidate the role of AGEs in the progression of diabetic nephropathy, the present study was undertaken to localize glomerular AGEs immunohistochemically. Ultrastructural changes of the mesangial matrix were analyzed with high resolution scanning electron microscopy. No glomerular AGEs staining was noted in normal control kidney specimens, or in tissue from glomerulonephritis patients without diabetes mellitus. The mesangium showed a positive AGEs staining in advanced stages of diabetic nephropathy, and the most characteristic finding was the strong AGEs staining in nodular lesions. By high resolution scanning electron microscopy, control and diabetic mesangial matrices revealed a meshwork structure composed of fine fibrils (10 nm in width) and numerous pores (12 to 13 nm in diameter). In the nodular lesions, however, loosening of the meshwork was significant, and the diameter of the pores was enlarged (approximately 24 nm). This study provides the first immunohistochemical evidence that AGEs are localized in diabetic glomeruli, most notably to nodular lesions. Advanced glycation might play a role in the progression of diabetic nephropathy through impairment of the assembly of matrix proteins in vivo.",
author = "Hirofumi Makino and Kenichi Shikata and K. Hironaka and M. Kushiro and Y. Yamasaki and H. Sugimoto and Z. Ota and N. Araki and S. Horiuchi",
year = "1995",
language = "English",
volume = "48",
pages = "517--526",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Ultrastructure of nonenzymatically glycated mesangial matrix in diabetic nephropathy

AU - Makino, Hirofumi

AU - Shikata, Kenichi

AU - Hironaka, K.

AU - Kushiro, M.

AU - Yamasaki, Y.

AU - Sugimoto, H.

AU - Ota, Z.

AU - Araki, N.

AU - Horiuchi, S.

PY - 1995

Y1 - 1995

N2 - Advanced protein glycation has been proposed as a major factor in the development of diabetic nephropathy. Advanced glycation end products (AGEs) have altered the structure of extracellular matrix component and impaired self association in vitro. To elucidate the role of AGEs in the progression of diabetic nephropathy, the present study was undertaken to localize glomerular AGEs immunohistochemically. Ultrastructural changes of the mesangial matrix were analyzed with high resolution scanning electron microscopy. No glomerular AGEs staining was noted in normal control kidney specimens, or in tissue from glomerulonephritis patients without diabetes mellitus. The mesangium showed a positive AGEs staining in advanced stages of diabetic nephropathy, and the most characteristic finding was the strong AGEs staining in nodular lesions. By high resolution scanning electron microscopy, control and diabetic mesangial matrices revealed a meshwork structure composed of fine fibrils (10 nm in width) and numerous pores (12 to 13 nm in diameter). In the nodular lesions, however, loosening of the meshwork was significant, and the diameter of the pores was enlarged (approximately 24 nm). This study provides the first immunohistochemical evidence that AGEs are localized in diabetic glomeruli, most notably to nodular lesions. Advanced glycation might play a role in the progression of diabetic nephropathy through impairment of the assembly of matrix proteins in vivo.

AB - Advanced protein glycation has been proposed as a major factor in the development of diabetic nephropathy. Advanced glycation end products (AGEs) have altered the structure of extracellular matrix component and impaired self association in vitro. To elucidate the role of AGEs in the progression of diabetic nephropathy, the present study was undertaken to localize glomerular AGEs immunohistochemically. Ultrastructural changes of the mesangial matrix were analyzed with high resolution scanning electron microscopy. No glomerular AGEs staining was noted in normal control kidney specimens, or in tissue from glomerulonephritis patients without diabetes mellitus. The mesangium showed a positive AGEs staining in advanced stages of diabetic nephropathy, and the most characteristic finding was the strong AGEs staining in nodular lesions. By high resolution scanning electron microscopy, control and diabetic mesangial matrices revealed a meshwork structure composed of fine fibrils (10 nm in width) and numerous pores (12 to 13 nm in diameter). In the nodular lesions, however, loosening of the meshwork was significant, and the diameter of the pores was enlarged (approximately 24 nm). This study provides the first immunohistochemical evidence that AGEs are localized in diabetic glomeruli, most notably to nodular lesions. Advanced glycation might play a role in the progression of diabetic nephropathy through impairment of the assembly of matrix proteins in vivo.

UR - http://www.scopus.com/inward/record.url?scp=0029143092&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029143092&partnerID=8YFLogxK

M3 - Article

VL - 48

SP - 517

EP - 526

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 2

ER -